JINYU BIO-TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.81 CNY | -0.34% |
|
-1.67% | -18.20% |
| Feb. 27 | Taihe Technologies' Chief Financial Officer Resigns | MT |
| 2023 | Jinyu Bio-Technology's Unit Ties Up With Shanghai Lanque Biomedicine for African Swine Fever Vaccine Development | MT |
| Sales 2023 * | 1.74B 240M | Sales 2024 * | 2.1B 290M | Capitalization | 9.58B 1.32B |
|---|---|---|---|---|---|
| Net income 2023 * | 304M 41.99M | Net income 2024 * | 402M 55.53M | EV / Sales 2023 * | 4.79 x |
| Net cash position 2023 * | 1.25B 172M | Net cash position 2024 * | 1.34B 185M | EV / Sales 2024 * | 3.92 x |
| P/E ratio 2023 * |
31.3
x | P/E ratio 2024 * |
24.6
x | Employees | 1,618 |
| Yield 2023 * |
1.4% | Yield 2024 * |
1.56% | Free-Float | 80.2% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.34% | ||
| 1 week | -1.67% | ||
| Current month | +1.26% | ||
| 1 month | +0.34% | ||
| 3 months | -7.46% | ||
| 6 months | +0.92% | ||
| Current year | -18.20% |
1 week
8.65
9.03
1 month
8.559.70
Current year
6.9410.93
1 year
6.9411.59
3 years
6.9422.10
5 years
6.9431.15
10 years
6.9431.15
| Managers | Title | Age | Since |
|---|---|---|---|
Min Peng
DFI | Director of Finance/CFO | 38 | 21-04-30 |
Jing Zhang
PSD | President | 41 | - |
Yi Kun Liu
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhen Ping Wu
BRD | Director/Board Member | 56 | 22-05-30 |
Chong Yu Zhang
CHM | Chairman | 70 | 04-05-26 |
Chang E Shen
BRD | Director/Board Member | 61 | 19-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 8.81 | -0.34% | 8,709,741 |
| 24-04-18 | 8.84 | -0.23% | 10,811,450 |
| 24-04-17 | 8.86 | +2.19% | 10,619,760 |
| 24-04-16 | 8.67 | -2.91% | 14,922,620 |
| 24-04-15 | 8.93 | -0.33% | 15,325,800 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotes
JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy products.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
8.81
CNY
Average target price
9.475
CNY
Spread / Average Target
+7.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.20% | 1.32B | |
| -13.09% | 6.38B | |
| +15.00% | 3.41B | |
| +4.59% | 3.36B | |
| +2.70% | 1.46B | |
| -6.15% | 1.21B | |
| -29.51% | 1.18B | |
| -18.20% | 1.07B | |
| -2.50% | 1.02B | |
| -9.78% | 800M |
- Stock Market
- Equities
- 600201 Stock
